Next-generation Sequencing Market Value Surpass USD 24.48 Billion by 2030

The global next-generation sequencing market size is estimated to generate revenues of more than USD 24.48 billion by 2030, growing at a CAGR of around 16.1% from 2022 to 2030

The report covers SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. The report offers an analysis of the global next-generation sequencing Market for the period 2017 to 2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.

The wide application portfolio of next-generation sequencing market is one of factors driving the growth of market worldwide. The global market is moderately competitive with a blend of global and regional players. The markets key players invest significantly in R and D to enhance their offerings. The entire ecosystem is composed of multiple participants. Every participant of the ecosystem is an equal contributor to the growth of global market.

Why should you invest in this report?

If you are aiming to enter the global next-generation sequencing Market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for next-generation sequencing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly. Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Report Structure:

• pertinent market numbers of the global next-generation sequencing market along with the CAGR for the forecast period 2022-2030
• detailed definitions of different types of next-generation sequencing, which gives clarity about what this market is all about and also defines the scope of this report
• macroeconomic factors influencing the global next-generation sequencing market, along with market opportunity analysis
• key trends likely to impact the global next-generation sequencing market
• PESTLE analysis of all the regions as per the market taxonomy
• Porter’s Five Force Analysis of all the regions as given in the market taxonomy

Global market analysis and forecast:

• the global next-generation sequencing market analysis and forecast by product type, by application, by region and others
• key market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the global next-generation sequencing market

Regional market analysis and forecast:

• Regional next-generation sequencing market analysis and forecast
• Regional market dynamics including the drivers, restraints and trends applicable across different regions in the next-generation sequencing market along with factors encouraging the growth of this market as well as the factors hampering the growth of this market
• Regional trends – both long term and short term

View Full Report@ https://www.precedenceresearch.com/next-generation-sequencing-market

Competitive landscape:

• the competitive landscape of this global report
• information on the various leading companies in the global market
• a dashboard view of the key companies operating in the global market along with their important information and broad strategy adopted to stay as leaders in the global market
• key company profiles along with important information such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis

Some of the prominent players in next-generation sequencing market include:

• BGI Group
• F. Hoffmann-La Roche AG
• Pacific Biosciences of California Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Precigen Inc.
• Illumina Inc.
• Qiagen N.V.
• PerkinElmer Inc.
• PierianDx Inc.

Market Segmentation:

By Product

• Consumables Platforms
• Services and Nerve Blockers

By Application

• Diagnostics
• Biomarkers and Cancer
• Reproductive Health
• Personalized Medicine
• Agriculture and Animal Research
• Others

By Technology

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single Molecule Real Time Sequencing
• Others

By End User

• Academic and Research Centers
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Clinical Research
• Others

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of the World

Research Methodology

In this report, historical data, primary responses and public domain data has been thoroughly analyzed to infer the market size. Revenue of companies operating in the global market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to determine the market size for the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and extensively scrutinized using advanced tools to garner quantitative and qualitative insights into the global next-generation sequencing.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Next Generation Sequencing Market 

5.1. COVID-19 Landscape: Next Generation Sequencing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Next Generation Sequencing Market, By Product

8.1. Next Generation Sequencing Market, by Product Type, 2021-2030

8.1.1. Consumables Platforms

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Services and Nerve Blockers

8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Next Generation Sequencing Market, By Application

9.1. Next Generation Sequencing Market, by Application, 2021-2030

9.1.1. Diagnostics

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Biomarkers and Cancer

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Reproductive Health

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Personalized Medicine

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Agriculture and Animal Research

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Next Generation Sequencing Market, By Technology Type 

10.1. Next Generation Sequencing Market, by Technology Type, 2021-2030

10.1.1. Sequencing by Synthesis

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Ion Semiconductor Sequencing

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Sequencing by Ligation

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Pyrosequencing

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Single Molecule Real Time Sequencing

10.1.5.1. Market Revenue and Forecast (2019-2030)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Next Generation Sequencing Market, By End User Type 

11.1. Next Generation Sequencing Market, by End User Type, 2021-2030

11.1.1. Academic and Research Centers

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Pharmaceutical and Biotechnology Companies

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Hospitals and Clinics

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Clinical Research

11.1.4.1. Market Revenue and Forecast (2019-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Next Generation Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Technology Type (2019-2030)

12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

Chapter 13. Company Profiles

13.1. BGI Group

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. F. Hoffmann-La Roche AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Pacific Biosciences of California Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Thermo Fisher Scientific Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Agilent Technologies Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Precigen Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Illumina Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Qiagen N.V.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. PerkinElmer Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. PierianDx Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms       

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333      

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: http://www.marketstatsnews.com/

Follow us on LinkedIn | Twitter | Facebook